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Sulfur mustard (SM) is an alkylating agent that induces apoptosis and necrosis in cells. Fas-Fas ligand (FasL) interaction could
induce apoptosis as well. In this study, it was hypothesized that apoptosis might play an important role in the pathogenesis of
SM-induced lunginjury via Fas-FasL signalingpathway. In a case-control study, Fas and FasL levels, caspase-3activity and percent
of apoptotic cells were measured in bronchoalveolar lavage (BAL) ﬂuid of patients 20 years after exposure to sulfur mustard and
comparedwiththecontrolgroup.Results showthatFasandFasLlevelsweresigniﬁcantlyhigherinBALﬂuidcellsinpatientsgroup
compared with the control (P = .001). No signiﬁcant diﬀerences were observed between mild and moderate-severe groups. BAL
ﬂuid cells caspase-3 activity was notsigniﬁcantlydiﬀerent among the mild, moderate-severe, and control groups. The data suggest
that Fas-FasL-induced apoptosis was impaired in BAL ﬂuid cells of SM-exposed patients which might be one of the initiators of
pathogenesis in SM-induced lung injury in these patients.
1.Introduction
Sulfur mustard (SM) is a vesicant compound warfare agent
that causes acute and chronic eﬀects on diﬀerent organs fol-
lowing exposure. It was used against Iranians by Iraqies
during Iraq-Iran ware. The eyes, theskin, and therespiratory
tract are three principal target organs of SM toxicity [1, 2].
A main late pulmonary complication of SM is bronchiolitis
obliterans (BOs) [3–5]. However, the mechanism of SM-
induced respiratory injuries is not fully understood.
SM is an alkylating agent causing single- and double-
strand breaksintheDNAandalso reactswith RNA,proteins,
and lipid membranes. Thus, it leads to a disordered cell
metabolism, causing cell death [6, 7]. In vitro and in vivo
studies showed that SM induces time- and dose-dependent
apoptosis (physiological cell death) and necrosis (pathologi-
cal cell death) in cells [8–11].
Twomajorpathwayshavebeendescribedtotriggerapop-
tosis, namely the extrinsic pathway (death receptor pathway)
and the intrinsic pathway (mitochondrial pathway) within
the cell. Interestingly, both pathways seem to be involved
in SM-induced apoptosis [6, 12]. The extrinsic pathway is
activated by ligand-activated death receptors such as Fas
ligand- (FasL-) Fas [13]. The binding of Fas-FasL activates
caspases, cysteine proteases that recognize aspartate at their
substrate cleavage site, and induced apoptosis [14]. SM may
develop susceptibility to mutations in tumor suppressor,
suchas p53,to reduce bcl-2,and to activate caspase-3 invitro
[15].
SM injury to the respiratory system has been related to
apoptotic cell death. Several investigators have shown that
SM induces apoptosis in lung-derived cells and that the
eﬀector caspase-3 is activated in a dose- and time-dependent
manner after SM injury [12, 15]. In vivo study with rodent2 Journal of Toxicology
pulmonary tissue exposed to SM showed increased gene
expression of apoptosis-related genes [16]. However, little is
known about the signal transduction pathways activated by
long-term eﬀects of SM. The purpose of the present study
was to investigate the mechanism of cell death via Fas-FasL
pathway that occurred in brochoalveolar lavage (BAL) ﬂuid
of patients 20 years after exposure to sulfur mustard. Un-
derstanding the molecular and cellular pathways activated in
response to SM exposure can lead to therapeutic strategies
for prevention or treatment of SM toxicity.
2.Materialsand Methods
2.1.PatientsGroup. Twenty patientswithhistoryofexposure
to a single high dose of SM from 1985 to 1987 during the
Iran-Iraq war who suﬀered from persistent respiratory and
chest discomfort, shortness of breath, cough, and exercise
intolerance were reviewed systematically. These patients
were selected among all those who were referred to the
Emergency Department of Baqiyatallah Hospital as the main
referralcenterforchemicallyinjuredpatientsinTehran,Iran.
The documentation of SM exposure was based on oﬃcial
certiﬁcation issued by the Iranian Veterans Foundation,
which is the oﬃcial center for compensation of war-disabled
victims. Patients with a history of smoking and occupational
exposure to toxicagentsand having dusty jobswere excluded
from the study.
2.2. Control Group. Six healthy volunteers, nonsmoking in-
dividuals with no history of SM exposure and no signs or
symptoms of respiratory disease were includedas the control
group. Ethical approval for this research was obtained from
the Ethics Committee of the Baqiyatallah University of Med-
ical Sciences, and informed consent was obtained from all
patients.
2.3. Pulmonary Function Test (PFT). To assess pulmonary
function using spirometry (Hi801 Chest M.I. Spirometer),
the residual volume (RV),forced vital capacity (FVC),forced
expiratory volume in 1 second (FEV1), and FEV1/ FVC were
measured. Based on postbronchodilator FEV1, patients were
divided into two groups: mild (n = 10) and moderate-to-
severe (n = 10) pulmonary dysfunction [17].
2.4. Bronchoscopy and BAL Sampling. BAL was performed
in all subjects using a ﬂexible ﬁber-optic bronchoscope
(Olympus BF1T, Tokyo, Japan). The upper respiratory tract
was anesthetized with 2% lidocaine. Atropine (0.75mg in-
tramuscularly) was administered before the procedure. Sup-
plemental oxygen was given throughout the procedure, and
the oxygen saturation was monitored by continuous pulse
oxymeter. The bronchoscope was wedged for lavage in the
middle lobe segmental bronchus, and four 60-mL aliquots
of sterile physiological saline solution warmed to 37◦Cw e r e
infused. The ﬂuid was immediately recovered by gentle suc-
tion after each instillation. After that brushing was obtained
from each patient via disposable cytology brush (Olympus
BC-202D-C10, Tokyo, Japan) in order to increase epithelial
cell number. The cell suspension has been centrifuged at
500g for 10 minutes in 4◦C. Cell plates were washed by cold
PBS buﬀer and were stored in −70◦C. For cell sampling,
a catheter was introduced via the sampling channel. The
sleeve was retracted, and the bristles were exposed. The
brush was then rubbed against the epithelial surface under
direct visual guidance. The brush was then retracted, and the
dissociated cells were well recovered by vortexing the brush
in BAL for several seconds; brushing was repeated in three to
four locations in the distal trachea and proximal main stem
bronchi [18].
2.5. Fas Level Assay. BAL ﬂuid cells Fas level was measured
using the RayBio human Fas ELISA kit (Cat NO. ELH-Fas-
001, USA). Standards and samples were pipetted into the
wells. Presented Fas in samples was bound to the wells by the
immobilized antibody. The wells were washed, and biotiny-
latedantihuman Fasantibodywasadded.Afterwashing away
unbound biotinylated antibody, HRP-conjugated strepta-
vidin was pipetted to the wells. The wells were again washed,
and a tetramethylbenzidine (TMB) substrate solution was
added to the wells and color developed in proportion to the
amount of Fas bound. The stop solution has changed the
color from blue to yellow, and the intensity of the color was
measured at 450nm.
2.6. Fas Ligand Level Assay. BAL ﬂuid cells FasL level was
measured with Fas Ligand “sandwich” ELISA kit (Cat no.
QIA27, Oncogene Research Products, USA). Samples and
biotinylated detector monoclonal antibody were pipetted
into the wells and allowed to incubate for three hours.
During this time, presented FasL was bound to the capture
and detecting antibodies. Unbound material was washed
away, and horseradish peroxidase-conjugated streptavidin
was added, which is bound to the detector antibody. The
horseradish peroxidase catalyzed the conversion of the chro-
mogenic substrate tetramethylbenzidine (TMB) from a col-
orless solutionto a bluesolution(oryellow afterthe addition
ofstopreagent).Itsintensity wasproportionaltotheamount
of FasL protein in the sample. The colored reaction product
was quantiﬁed using a spectrophotometer by the construc-
tion of a standard curve using known concentrations of FasL
(provided lyophilized). The concentration of FasL in the
sample could be determined by comparing the absorbance
obtained from a sample containing an unknown amount of
FasL with that standard.
2.7. Caspase-3 Activity Assay. Caspase-3 activity was mea-
sured with caspase ELISA kit (Cat no. C2087-12, CPP32,
Apotain, Yama, SCA-1, US Biological Company). Brieﬂy,
100μL cell lysate or 1 unit recombinant human caspase-3
(positive control) was added to antibody-coated well. The
plate was tightly covered and incubated at 37◦C for 1 hour.
Then, the solutions were removed and after washing 3
times with 150μLi n c u b a t i o nb u ﬀer. Then, 94μLi n c u b a t i o n
buﬀers, 5uL DEVD-AFC, and 1μL DTT were added to each
well. The plate was tightly covered and incubated at 37◦Cf o r
2–4 hours. The samples were read at Ex: 370–425nm andJournal of Toxicology 3
Table 1: Characteristics of the study populations.
Control Mild Moderate-severe P value
(n = 6) (n = 10) (n = 10)
Sex Male Male Male —
Age 38.7 ±6.13 9 .5 ±5.44 3 .5 ± 5.3. 1 2
Height 172.2 ±3.7 174.5 ±6.3 168.3 ± 4.5. 4 2
Weight 74.5 ±9.87 4 .3 ±10.87 5 .4 ± 10.5. 6
Values are shown as mean ± SD.
Table 2: The pulmonary function indices of the study populations.
Control Mild Moderate to severe
(n = 6) (n = 10) (n = 10)
RV (% predicted) 105.9 ±9.6 130.2 ±27.7 160.3 ±62.5
FVC (% predicted) 88.2 ±5.96 9 .7 ± 18.1
∗ 66.1 ±13.2
∗
FEV1 (% predicted) 90.7 ±6.57 5 .3 ± 16.85 8 .2 ± 17.6
∗∗
FEV1/FVC (%) 88 ±5.88 7 .2 ±9.3
# 65.4 ±8.7
∗∗∗
Values are shown as mean ± SD. ∗P<. 05, ∗∗P<. 01, and ∗∗∗P<. 001
versus control. #P<. 001 versus moderate-severe group.
Em: 490–525nm in a ﬂuorescence microtiter plate reader.
The notable increase in caspase-3 activity was determined by
comparing the results with uninduced control.
2.8. Detection of Apoptosis Using Annexin V. To detect phos-
phatidylserine, annexin V-FITC (Trevigen Inc., Gaithers-
burg, USAorBoehringer Mannheim, GmbH, Germany) was
used in a combination with propidium iodide (PI) using
Apopnexin FITC Apoptosis Detection Kit (Katayama Chem-
ical, Osaka, Japan). The FITC-Annexin V ﬂuorescence was
read with the FL1 photomultiplier tube, and PI ﬂuorescence
was detected using the FL3 channel.
2.9. Protein Concentration Assay. The total protein concen-
trationin BALFwas measured byBranford’s method31using
bovine serum albumin as standard [19].
2.10. Statistical Analysis. SPSS 15.0 (SPSS Inc, Chicago, IL,
USA) was used for statistical analysis. Comparisons between
the patients and control groups and also between subgroups
of patients were assessed by one-way ANOVA. Signiﬁcant
diﬀerences between means were analysed by the post-hoc
test using Scheﬀe’s F. Spearman’s rank correlation coeﬃcient
was used to analyse correlations between serum markers.
Data was shown as means ± SD. P-values less than .05 were
considered statistically signiﬁcant.
3.Results
3.1. Control and Case Group Demographic Information.
Comparison of mean age among the control (38.7 ± 6.1)
and patients groups with mild (39.5±5.4)and moderate-to-
severe (43.5±5.3)disease didnot show signiﬁcantly diﬀerent
(P = .24) (Table 1).
Table 3: Diﬀerential percentage counts of BAL ﬂuid cells.
Control Mild Moderate to severe
(n = 6) (n = 10) (n = 10)
PMN (%) 10.6 ±1.73 .8 ±1.71 8 .6 ± 11.3
Lymph (%) 2.5 ±0.52 .3 ±0.83 .4 ± 1.5
Macrophage (%) 85 ±21 93.8 ±2.36 8 ± 21
Values are shown as means ± SD.
3.2. PFT Finding. As described in Table 2,F V C ,F E V 1a n d
FEV1/FVC ratio was signiﬁcantly lower in patients with
moderate-to-severe and FVC in patients with mild respira-
tory disease compared with the control group. FEV1/FVC
ratio was signiﬁcantly higher inpatientswith mild compared
with moderate-to-severe respiratory disease (P = .001).
3.3. Diﬀerential Cell Count. Diﬀerential BAL ﬂuid cell count
showed that there was not signiﬁcant diﬀerence in polymor-
phonuclear(PMN),macrophages, and lymphocytesbetween
the severe and the control group. There was only a diﬀerence
observed inPMN between the mild and control group. PMN
was signiﬁcantly lower in mild group (P<. 05) (Table 3).
3.4. BAL Fluid Fas and FasL Levels in the Patient and Control
Group. As displayed in Figure 1, the Fas and FasL levels
in the BAL ﬂuid cells of patient with mild and moderate-
to-severe lung dysfunction are signiﬁcantly higher than the
control group. There were not any signiﬁcant diﬀerences
between the mild and moderate-to-severe groups (P>. 05).
3.5. BAL Fluid Caspase-3 Activity in the Patient and Control
Group. BAL ﬂuid cells Caspase-3 activity in the patient and
control group is shown in Figure 2.T h e r ew a sn o ta n y
signiﬁcant diﬀerence in BAL ﬂuid cells caspase-3 activity
between the control and patient groups (P>. 05).
3.6. Percent of Apoptotic and Necrotic Cells in the Patient
and Control Group. As seen in Figure 3,t h e r ew a sn o ta n y
signiﬁcant diﬀerence in percent of apoptotic and necrotic
cells of BAL ﬂuid between the control and patient groups.
Percent of apoptotic cells is lower than late necrotic cells.
4.Discussion
Apoptosis, programmed cell death, is known to participate
in various biological processes such as development, main-
tenance of tissue homeostasis, and elimination of cancer
cells. Malfunctions of apoptosis have been implicated in
many forms of human diseases [20, 21]. The potential role
of the Fas receptor pathway in asthma has been intensively
studied during recent years, albeit with contradictory results.
Some studies have demonstrated a decreased expression
of Fas receptor or Fas ligand [22] in asthmatic subjects,
while other studies have reported an increased expression
of Fas receptor and Fas ligand in asthmatic subjects [23].
Several studies showed that SM induces apoptosis by both4 Journal of Toxicology
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Figure 1: Fas and FasL levels in the normal, mild and moderate-
to-severe patient groups. Values are shown as mean ± SD. ∗P<. 05
versus control.
Control Mild
0
2
4
6
8
10
12
C
a
s
p
a
s
e
-
3
(
U
/
m
g
p
r
o
t
e
i
n
)
Moderate-to-severe
Figure 2: Caspase-3activity inthe normal,mild, and moderate-to-
severe patient groups. Values are shownas mean ± SD.
the intrinsic mitochondrial pathway and the extrinsic Fas-
Fas ligand pathway [12, 15, 24–27]. In this study, there was
signiﬁcant increase in BAL ﬂuid cells Fas and FasL levels
in mild and moderate-to-severe patients compared to the
control. FEV1/FVC ratio which is more sensitive for air
way obstruction was signiﬁcantly higher in patients with
milddisordercomparedwithmoderate-to-severerespiratory
disease. It indicates that the patients with moderate-to-
severe symptoms are more prone to airway obstruction.
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Figure 3: Percent of apoptotic and late necrotic cells of BAL ﬂuid
cells in the normal, mild, and moderate-to-severe patient groups.
Values are shownas mean ± SD.
Our ﬁndings are concurrent with previously studies that
reported increased Fas and FasL levels in BAL ﬂuid of the
patients with BO and acute respiratory distress syndrome
compared with their corresponding control group. It has
beensuggestedthatitmightplayimportantroleinpathology
of respiratory dysfunction [28–30]. Rosenthal et al. [24]
have shown that SM exposure destabilizes intracellular p53
leading to enhanced Fas receptor and FasL expression in
human keratinocytes at vesicant SM concentrations. Ray
et al. [31], also reported that acute exposure to various
mustard concentrations would inducesapoptotic pathway in
normal human bronchial epithelial cells and small airway
epithelial cells via caspase-mediated pathway in vitro. A
recent study reported that soluble FasL was increased in
serum of SM-exposed patients [32].
Caspases are protease enzymes that play important
role in the apoptosis process. Both extrinsic and intrinsic
apoptotic pathways activate caspase-3 which is the exe-
cutioner caspase responsible for the end eﬀects in the
apoptosis process [12, 33, 34]. Previous studies showed that
caspase activity is involved in the cell death pathway that
is induced following exposure to mild concentrations of
SM [11, 15, 24, 31, 35]. In present study, there was no
diﬀerence in BAL ﬂuid cells caspase-3 activity among patient
andcontrolgroups.Sincecaspase-3isconsideredtobeoneofJournal of Toxicology 5
the main eﬀector caspases in apoptotic cell death, it could
be concluded that apoptosis was impaired in BAL ﬂuid
cells of patient population. Caspase-3 is normally present
in the cells in an inactive zymogens form and requires
proteolytic processing before they become active. Cleavage
is aﬀected by the context of large multiprotein complexes
known as DISC (death-inducing signaling complex) and
the apoptosome, the formation of which requires several
adaptor proteins [33, 34]. It could be assumed that SM
exposure might aﬀect apoptosis process by aﬀecting a variety
offactors. Asecond type ofregulatory proteins that might be
aﬀected in SM-exposed patients could be FLICE inhibitory
protein (FLIP). FLIP is able to block early events in Fas and
TNF-receptor-like apoptosis-inducing ligand (TRAIL)/TNF
family death receptor signaling by precluding caspase-8
recruitment to the DISC. FLIP is a caspase-8-like protein
that interferes with caspase-8 binding to the DISC, thus
preventing caspase-8 oligomerization and autoactivation
[36, 37]. Finally, SM exposure might activate the inhibitor
of apoptosis proteins (IAPs), which constitutes a family of
evolutionarily conserved apoptotic suppressors. Members
of the IAP-family proteins, such as X-linked inhibitor of
apoptosis protein (XIAP), have been shown to bind to and
inhibit activated caspase-3, -7, and -9 [38].
Therefore, it could be concluded that in SM-exposed
patients one of these inhibitory factors might be activated
andprevented,theFas-FasL-inducedapoptosis.Patientsexp-
erienced inhalation injury have developed BO, which was
conﬁrmed with pathology and high-resolution CT studies
[39, 40]. Besides ourclinical data, pathologic ﬁnding showed
that there was no diﬀerences between the low- and high-
dose SM exposure after 20 years of initial SM exposure,
suggesting that SM eﬀects are not dependant on exposure
severity [4]. Lung disease in this group of patients showed
a slowly progressive nature. Long-term medical followup
after exposure revealed that approximately 75%–80% of our
patients experienced mild respiratory impairment and only
20% of them developed severe disease [41]. This ﬁnding
was conﬂicting to posttransplant BO which is marked by
progressive obstructive lung disease leading to a progressive
decline in FEV1 caused by an inﬂammatory process of
the airways identical with chronic allograft rejection [42].
It seems that the major diﬀerence is due to the etiology of
lunginjury, inwhich over20yearsafterexposure mostofour
patients have shown that their disease has slowly progressive
diseasenature, but not experienced without any cure even
with diﬀerent medications. It seems that optimal apoptotic
pathway cascades (eﬀerocytosis) are not triggered eﬃciently.
Most in vitro and in vivo studies have planned to investigate
cellular damage after a short time of injury, which represents
the acute eﬀect and cellular changes [11, 15, 24, 31, 35].
Phosphatidylserine is normally exposed on inner side
of plasma membranes, and it becomes exposed on outer
membrane surface of the cells undergoing apoptosis. There-
fore, annexin V-FITC is able to detect the surface changes
in membrane surface that occur early during apoptosis
[43]. In this study, further analysis of BAL ﬂuid cells with
Annexin V-FITC versus propidium iodide conﬁrmed that
the majority of cells became necrotic and only a small
portionbecameapoptosis.Duringapoptosis,thecellshrinks,
while producing apoptotic bodies which are taken up by
neighboring cells by phagocytosis. Very little cytoplasmtic
material is released into the intercellular space and no or
limited inﬂammation is caused in neighboring tissues. In
contrast, during necrosis, the cellular contents are released
uncontrolled into the cell’s environment which results in
damage of surrounding cells and a strong inﬂammatory
response in the corresponding tissue [20, 21]. Based on
previous reports, lung diseases are related to inﬂammatory
processes that generate increased reactive oxygen species
that correlate with disease severity [44–46]. Additionally,
SM upregulates many inﬂammatory mediators including
interleukin- (IL-) 1alpha, IL-1beta, IL-6, IL-8, tumor necro-
sis factor-alpha (TNF-alpha) and others [47–49]. The main
ﬁndings of lavage ﬂuid of sulfur mustard-injured patients
are inﬂammation, tissue damage, and neutrophil excess [46].
The neutrophils were shown to produce several cytokines
such as tumor necrosis factor and transforming growth
factor-β, as an inﬂammatory factor [50], and express Fas lig-
and [32,50].Astudyshows thattransforming growthfactor-
β plays a pivotal role in bronchiolitis obliterans pathogenesis
[51]. A recent study shows that the level of transforming
growth factor-β is signiﬁcantly increased in lavage ﬂuid
of patients with sulfur mustard-exposure, compared with
veterans not exposed to sulfur mustard [52]. A 6-month
treatment with gamma interferon, an anti-inﬂammatory
eﬀect via down-regulation transforming growth factor-β
gene expression, is associated with an improvement in the
lung function in sulfur mustard exposed patients with bron-
chiolitis [53]. However, recent studiesshowed that theserum
levels of inﬂammatory cytokines such as IL-8, IL-6 [54],
IL-1alpha, IL-1beta, and TNF-alpha, except for IL-1Ra and
MMP-9 [55], decreased in SM-exposed subjects. More local
studies on the lung are needed to clarify the exact role of this
cytokines and inﬂammation.
5.Conclusion
Our study showed that SM exposure inhibited Fas-FasL-
inducedapoptosisinBALﬂuidcellsofexposed patients.This
inhibition might change PMN, granulocyte and lymphocyte
turnover aﬀect cytokine, chemokine, and protein secretion
from these cells, and potentiate initiation of lung injury in
SM-exposed patients. In future studies, exact mechanism of
this inhibition should be addressed for probable therapeutic
application. In addition, nonapoptotic importance of Fas-
FasL-like macrophage and PMN activation could be inves-
tigated.
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